Skip to main content

Editorial Board

Editors-in-Chief
Franco M Buonaguro, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy
Maria Lina Tornesello, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" , Italy

Section Editor for  “Cancer centers in low- and middle-income countries"
Sam M Mbulaiteye, MBChB, M.Phil., M.Med, National Cancer Institute, USA

Associate Editors
Luigi Buonaguro, MD, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Italy
Valli De Re, PhD, Centro di Riferimento Oncologico, Italy
Kanan Desai,  MD, MPH, US National Cancer Institute, USA
Paola Di Bonito, MD, Istituto Superiore di Sanità, Italy
Renato Franco, PhD, Università degli Studi della Campania Luigi Vanvitelli, Italy
Paolo Giorgi Rossi, MD, AUSL Reggio Emilia, IRCCS, Italy
Tetsuya Ikeda, DDS, PhD, Kyorin University,  Japan
Maria Issagouliantis, MD, Karolinska Institutet, Sweden 
Rubén López-Revilla, MD, Instituto Potosino De Investigation Cientifica Y Tecnologica, Mexico
Luiz Machado, MD, Federal University of Parà, Brazil
Camille Ragin, PhD, MPH, Fox Chase Cancer Center, USA
Mihir S Rajurkar, PhD, Massachusetts General Hospital, USA
Laura Sichero, PhD, Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - ICESP, Brasil
J.H. Zhong, MD, PhD, Guangxi Medical University, China

Section Editors
Clinical oncology
Serigne Magueye Gueye, PhD, General Hospital of Grand-Yoff, Senegal
Jan Vermorken, MD, PhD, Antwerp University Hospital, Belgium

African cancers
Twalib Ngoma, PhD, Muhimbili University of Health and Allied Sciences, Tanzania
Henry R Wabinga, PhD, Makerere University, Uganda

Cancer centers in low- and middle-income countries
Kishor Bhatia, PhD, National Cancer Institute, USA

Advisory Board
Arséne Burny, PhD, University of Brussels, Belgium
Ethel-Michele de Villiers, PhD, German Cancer Research Center, Germany
Professor Volker Erfle, PhD, Institute for Molecular Virology, Germany
Silvia Franceschi, MD, International Agency for Research on Cancer, France
Robert Gallo, PhD, University of Maryland, USA
Denise DG Galloway, PhD, Fred Hutchinson Cancer Research Center, USA
Eva Klein, PhD, Karolinska Institute, Sweden
Jay Nelson, PhD, Oregon Health & Sciences University, USA
Joseph S Pagano, PhD, University of North Carolina, USA
Giorgio Palu, PhD, University of Padua, Italy
Bernard Roizman, PhD, University of Chicago, USA

Editorial Board
Francisco Aguayo, PhD, University of Chile, Chile
Niyaz Ahmed, PhD, University of Hyderabad, India
Adriana Albini, MD, IRCCS Multimedica, Italy
Richard Ambinder, PhD, John Hopkins University, USA
Charles Bangham, PhD, Imperial College London, UK
Filippo Belardelli, MD, Istituto Superiore di Sanità, Italy
Valerie Beral, PhD, University of Oxford, UK
Yuan Chang, PhD, University of Pittsburgh Cancer Institute, USA
Massimo Clementi, PhD, Vita-Salute San Raffaele University, Italy
Riccardo Dolcetti, MD, Centro di Riferimento Oncologico, Italy
Reza Farid, PhD, University of Mashhad, Iran
Marisa Gariglio, MD, PhD, University of Eastern Piedmont, Italy
Tarik Gheit, MD, International Agency for Research on Cancer, France
Wenlin Huang, PhD, Sun Yat-sen University, China
Shuji Izumo, PhD, Kagoshima University, Japan
Steven Jacobson, PhD, National Institutes of Health, USA
Andrei Kozlov, PhD, St Petersburg State University, Russia
Hung-Jen Liu, PhD, National Chung Hsing University,Taiwan
Lucia Lopalco, PhD, San Raffaele Scientific Institute, Italy
Luiz Fernando Almeida Machado, PhD, Federal University of Pará, Brazil
Alberto Mantovani, PhD, University of Milan, Italy
Ponsiano Ocama, PhD, Makerere University College of Health Science, Uganda
Maurizio Provenzano, MD, PhD, University Hospital of Zurich, Switzerland
Mihir S Rajurkar, PhD, Harvard Medical School,  USA
Brian Salmons, MD, Austrianova, Singapore
Professor Thomas Schulz, PhD, University of Hannover, Germany
Shivendra Tenguria, PhD, Purdue University, USA
Claudio Tiribelli, PhD, Fondazione Italiana Fegato, Italy
Aldo Venuti, MD, PhD, Regina Elena National Cancer Institute, Italy
Huizhi Wang, MD, MS, PhD, Virginia Commonwealth University, Richmond, USA
Yoshihiko Yano, MD, PhD, Kobe University Graduate School of Medicine, Japan
Robert Yarchoan, MD, National Institutes of Health, USA
Jian-Hong Zhong, PhD, Guangxi Medical University, China
Axel zur Hausen, PhD, Maastricht University Medical Centre, The Netherlands

Annual Journal Metrics

  • 2022 Citation Impact
    3.7 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.040 - SNIP (Source Normalized Impact per Paper)
    0.583 - SJR (SCImago Journal Rank)

    2023 Speed
    14 days submission to first editorial decision for all manuscripts (Median)
    112 days submission to accept (Median)

    2023 Usage 
    687,750 downloads
    813 Altmetric mentions

What is trending?

Altmetric




               Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.